J&J’s sales improved in the first quarter of 2018. This is because the Pharmaceutical segment continued the positive momentum seen in the second half of 2017 and Consumer segment sales improved. The positive sales trend is expected to continue in the second quarter.
J&J (JNJ) to Set Pharma Q2 Earnings in Motion: What's Up?
Johnson and Johnson (JNJ) earnings preview: will increasing competition slow down the growth?
Do you think JNJ will continue to rise in the future?
Submitted July 13, 2018 at 02:59AM by BitBitWin https://ift.tt/2LeYCWL
No comments:
Post a Comment